Spinosad Suspension
Product Images NDC 28595-570

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Spinosad (NDC 28595-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Spinosad 01)

Chemical Structure (Spinosad 01)
FDA Label Image

Chemical Structure (Spinosad 02)

Chemical Structure (Spinosad 02)
FDA Label Image

Step 1 (Spinosad 03)

Step 1 (Spinosad 03)
FDA Label Image

Step 2 (Spinosad 04)

Step 2 (Spinosad 04)
FDA Label Image

Step 3 (Spinosad 05)

Step 3 (Spinosad 05)
FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

Principal Display Panel (120 mL Bottle Carton)
FDA Label Image

Spinosad 07

Spinosad 07
FDA Label Image

Spinosad 08

Spinosad 08
FDA Label Image

Spinosad 09

Spinosad 09
FDA Label Image

Spinosad 10

Spinosad 10
FDA Label Image

Spinosad 11

Spinosad 11
FDA Label Image

Spinosad 12

Spinosad 12
FDA Label Image

Spinosad 13

Spinosad 13
This text seems to be a set of directions for a topical suspension called Spinosad. It provides information on how to use the product, the recommended dosage, and precautions to take when using it. It includes a list of ingredients and advises to avoid contact with eyes and to keep the product out of reach of children. There is also information on how to handle eye contact and where to store the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.